Nitric oxide releasing nanoparticles are therapeutic for Acinetobacter baumannii wound infections

Virulence

Volumn 1, Issue 2, 2010, Pages 62-67

  Mihu, Mircea Radu ^a   Sandkovsky, Uriel ^a   Han, George ^a   Friedman, Joel M ^a   Nosanchuk, Joshua D ^a   Martinez, Luis R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Acinetobacter baumanii; Cytokine; Nanoparticles; Nitric oxide; Wound infection

Indexed keywords

ANTIINFECTIVE AGENT; COLLAGEN; CYTOKINE; NANOPARTICLE; NITRIC OXIDE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; DRUG TARGETING; FEMALE; HISTOPATHOLOGY; INFLAMMATION; MOUSE; NONHUMAN; WOUND HEALING; WOUND INFECTION;

ACINETOBACTER BAUMANNII; MURINAE;

EID: 77954950686     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.1.2.10038     Document Type: Article

References (38)

1. Bergogne-Berezin E. The Increasing Role of Acinetobacter Species As Nosocomial Pathogens. Curr Infect Dis Rep 2001; 3:440-4.
2. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical and epidemiological features. Clin Microbiol Rev 1996; 9:148-65.
3. Villegas MV, Hartstein AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 2003; 24:284-95.
4. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5:939-51.
5. Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 2005; 11:868-73.
6. Calhoun JH, Murray CK, Manring MM. Multidrug-resistant organisms in military wounds from Iraq and Afghanistan. Clin Orthop Relat Res 2008; 466:1356-62.
7. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21:538-82.
8. Perez F, Endimiani A, Bonomo RA, Why are we afraid of Acinetobacter baumannii? Expert Rev Anti Infect Ther 2008; 6:269-71.
9. Ghaffari A, Miller CC, McMullin B, Ghahary A. Potential application of gaseous nitric oxide as a topical antimicrobial agent. Nitric Oxide 2006; 14:21-9.
10. Martinez LR, Han G, Chacko M, Mihu MR, Jacobson M, Gialanella P, et al. Antimicrobial and Healing Efficacy of Sustained Release Nitric Oxide Nanoparticles Against Staphylococcus aureus Skin Infection. J Invest Dermatol 2009; 129:2463-9.
11. Mowbray M, Tan X, Wheatley PS, Rossi AG, Morris RE, Weller RB. Topically applied nitric oxide induces T-lymphocyte infiltration in human skin, but minimal inflammation. J Invest Dermatol 2008; 128:352-60.
12. Soneja A, Drews M, Malinski T. Role of nitric oxide, nitroxidative and oxidative stress in wound healing. Pharmacol Rep 2005; 57:108-19.
13. Friedman AJ, Han G, Navati MS, Chacko M, Gunther L, Alfieri A, Friedman JM. Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide 2008; 19:12-20.
14. Rabea EI, Badawy ME, Stevens CV, Smagghe G, Steurbaut W, Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 2003; 4:1457-65.
15. Qi L, Xu Z, Jiang X, Hu C, Zou X Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr Res 2004; 339:2693-700.
16. Cardenas G, Anaya P, von Plessing C, Rojas C, Sepulveda J. Chitosan composite films. Biomedical applications. J Mater Sci Mater Med 2008; 19:2397-405.
17. Karageorgopoulos DE, Kelesidis T, Kelesidis I, Falagas ME. Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. J Antimicrob Chemother 2008; 62:45-55.
18. Sebeny PJ, Riddle MS, Petersen K., Acinetobacter bau-mannii skin and soft-tissue infection associated with war trauma. Clin Infect Dis 2008; 47:444-9.
19. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51:3471-84.
20. Marletta MA, Tayeh MA, Hevel JM. Unraveling the biological significance of nitric oxide. Biofactors 1990; 2:219-25.
21. Rothrock AR, Donkers RL, Schoenfisch MH. Synthesis of nitric oxide-releasing gold nanoparticles. J Am Chem Soc 2005; 127:9362-3.
22. Shin JH, Metzger SK, Schoenfisch MH. Synthesis of nitric oxide-releasing silica nanoparticles. J Am Chem Soc 2007; 129:4612-9.
23. Polizzi MA, Stasko NA, Schoenfisch MH. Water-soluble nitric oxide-releasing gold nanoparticles. Langmuir 2007; 23:4938-43.
24. Hetrick EM, Shin JH, Paul HS, Schoenfisch MH. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials 2009; 30:2782-9.
25. Hetrick EM, Shin JH, Stasko NA, Johnson CB, Wespe DA, Holmuhamedov E, Schoenfisch MH. Bactericidal efficacy of nitric oxide-releasing silica nanoparticles. ACS Nano 2008; 2:235-46.
26. Hetrick EM, Prichard HL, Klitzman B, Schoenfisch MH. Reduced foreign body response at nitric oxide-releasing subcutaneous implants. Biomaterials 2007; 28:4571-80.
27. Isenberg JS, Tabatabai N, Spinelli HM. Nitric oxide modulation of low-density mononuclear cell transendothelial migration. Microsurgery 2005; 25:452-6.
28. Thornton FJ, Schaffer MR, Witte MB, Moldawer LL, MacKay SL, Abouhamze A, et al. Enhanced collagen accumulation following direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds. Biochem Biophys Res Commun 1998; 246:654-9.
29. Schaffer MR, Tantry U, Gross SS, Wasserburg HL, Barbul A. Nitric oxide regulates wound healing. J Surg Res 1996; 63:237-40.
30. Monboisse JC, Labadie J, Gouet P. Purification and physico-chemical properties of collagenase synthesized by a bacterium of the type Acinetobacter sp. Biochimie 1979; 61:1169-75.
31. Monboisse JC, Labadie J, Gouet P. Induction and repression of the collagenase synthesis in Acinetobacter sp. Can J Microbiol 1979; 25:611-7.
32. Monboisse JC, Labadie J, Gouet P. Attachment of a collagenolytic strain to its substrate (author's transl). Ann Microbiol 1979; 130:435-40.
33. Robson MC, Stenberg BD, Heggers JP, Wound healing alterations caused by infection. Clin Plast Surg 1990; 17:485-92.
34. Ma YM, Sun T, Liu YX, Zhao N, Gu Q, Zhang DF, et al. A pilot study on acute inflammation and cancer: a new balance between IFNgamma and TGFbeta in melanoma. J Exp Clin Cancer Res 2009; 28:23.
35. Takamiya M, Biwasaka H, Saigusa K, Nakayashiki N, Aoki Y., Wound age estimation by simultaneous detection of 9 cytokines in human dermal wounds with a multiplex bead-based immunoassay: An estimative method using outsourced examinations. Leg Med 2009; 11:186-90.
36. Kanangat S, Meduri GU, Tolley EA, Patterson DR, Meduri CU, Pak C, et al. Effects of cytokines and endotoxin on the intracellular growth of bacteria. Infect Immun 1999; 67:2834-40.
37. Mowbray M, McLintock S, Weerakoon R, Lomatschinsky N, Jones S, Rossi AG, Weller RB. Enzyme-independent NO stores in human skin: quantification and influence of UV radiation. J Invest Dermatol 2009; 129:834-42.
38. Adams MD, Goglin K, Molyneaux N, Hujer KM, Lavender H, Jamison JJ, et al. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J Bacteriol 2008; 190:8053-64.